Business Standard

Syncom Formulations (India) Share Price

Know More

12.66 0.28 (2.26%)

04:01 PM,12th Jun 2024

12.66 0.30 (2.43%)

03:54 PM,12th Jun 2024

BSE : 524470


Sector : Health care

ISIN Code : INE312C01025

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 12-Jun-2024 | 04:01 PM IST

Market Cap (₹ Cr)


Turnover (₹ Cr)


Volume (Shares)


Face Value


52-WK High


52-WK High Date


52-WK Low


52-WK Low Date


All Time High


All Time High Date


All Time Low


All Time Low Date


Syncom Formulations (India) Ltd

Incorporated as a private limited company in 1988 Syncom Formulations (India) Limited was converted into a public limited company in Jun.'92. The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency. Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur Madhya Pradesh. Established in 1988 Syncom plant is geared up with latest production machineries and maintains high quality standards. Currently the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets Capsules Liquids Orals Liquid Vials and Ampoule Injections & Dry Vial injections Dr...
Read More

Syncom Formulations (India) Ltd - Key Fundamentals

Market Cap (₹ Cr)


EPS - TTM (₹) [S]


P/E Ratio (X) [S]


Face Value (₹) 1
Latest Dividend (%)3.00
Latest Dividend Date 09-Sep-2022
Dividend Yield (%) -
Book Value Share (₹) [S]3.05
P/B Ratio (₹) [S]4.15

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Motilal Oswal S&P BSE Healthcare ETF 0.01 7,241 0.06

Research Reports

Date Broker Action Prices(₹) Report
Data Not Found

Stock Strength

Today's Low/High



Week Low/High



Month Low/High



Year Low/High



All time Low/High



Share Price Returns

1 Week9.61%9.61%2.993.11%
1 Month-2.99%-2.99%5.435.75%
3 Month-0.39%-0.31%3.994.42%
6 Month8.95%8.67%10.1411.56%
1 Year63.99%64.42%22.1325.38%
3 Year37.46%%45.9947.62%

Company Info

Company Information

Chairman & Wholetime Director : Kedarmal Bankda

Managing Director : Vijay Shankarlal Bankda

Independent Director : Vinod Kumar Kabra

Independent Director : Krishna Das Neema

Independent Director : Praveen Jindal

Whole-time Director : Rinki Bankda

Independent Director : Ruchi Jindal

Company Sec. & Compli. Officer : Vaishali Agrawal

Independent Director : Ritesh Kumar Lunkad

Independent Director : Ankit Jain

Registered Office: 7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd,Mumbai,Maharashtra-400093 Ph: 91-22-30887744;


FAQs about Syncom Formulations (India) Ltd

1. What's the Syncom Formulations (India) Ltd share price today?
Syncom Formulations (India) Ltd share price was Rs 12.66 at 04:01 PM IST on 12th Jun 2024. Syncom Formulations (India) Ltd share price was up by 2.26% over the previous closing price of Rs 12.38. Syncom Formulations (India) Ltd share price trend:

  • Last 1 Month: Syncom Formulations (India) Ltd share price moved down by 2.99% on BSE
  • Last 3 Months: Syncom Formulations (India) Ltd share price moved down by 0.39% on BSE
  • Last 12 Months: Syncom Formulations (India) Ltd share price moved up by 63.99% on BSE
  • Last 3 Years: Syncom Formulations (India) Ltd price moved up by 37.46% on BSE

2. How can I quickly analyse the performance of the Syncom Formulations (India) Ltd stock?
The performance of the Syncom Formulations (India) Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 50.64
  • Price to book value ratio is 4.15
  • Dividend yield of 0.00
  • The EPS (trailing 12 months) of the Syncom Formulations (India) Ltd stock is Rs 0.25

3. What is the market cap of Syncom Formulations (India) Ltd?
Syncom Formulations (India) Ltd has a market capitalisation of Rs 1,190 crore.

4. What is Syncom Formulations (India) Ltd's 52-week high/low share price?
The Syncom Formulations (India) Ltd’s 52-week high share price is Rs 18.65 and 52-week low share price is Rs 7.09.

5. Is the Syncom Formulations (India) Ltd profitable?
On a consolidated basis, Syncom Formulations (India) Ltd reported a profit of Rs 6.75 crore on a total income of Rs 76.14 crore for the quarter ended 2024. For the year ended Mar 2024, Syncom Formulations (India) Ltd had posted a profit of Rs 7.40 crore on a total income of Rs 77.67 crore.

6. Which are Syncom Formulations (India) Ltd’s peers in the Health care sector?
Syncom Formulations (India) Ltd’s top 5 peers in the Health care sector are Windlas Biotech, NGL Fine Chem, Lincoln Pharma., Syncom Formul., Anuh Pharma, Kopran, Bliss GVS Pharma.

7. Who owns how much in Syncom Formulations (India) Ltd?
Key changes to the Syncom Formulations (India) Ltd shareholding are as follows:

  • Promoter holding in Syncom Formulations (India) Ltd has gone up to 50.57 per cent as of Mar 2024 from 50.57 per cent as of Jun 2023.